Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just an FYI . . . Grewal denied TPL's motion to continue the trial.

Thank you. He made that decision rather quickly. Hopefully he will issue a decision on the motion for more clarification very soon. Is this what they are waiting for to issue a PR?

GL

Share
New Message
Please login to post a reply